Dr. Deepak Tripathi is a genomics strategic marketing professional with a PhD in Biochemistry specializing in protein biochemistry, biomarker discovery and validation in cancer research. With over 15 years of experience across academia and leading biotechnology companies, he has worked at the intersection of science, technology, and strategy helping translate complex genomic innovations into solutions that are meaningful for basic and translational researchers, clinicians, and biopharma partners.
Trained as a scientist and now working in a global marketing leadership role, Deepak Tripathi combines expertise in cryo electron microscopy, HPLC, qPCR, digital PCR, next-generation sequencing, and multi-omics workflows with a strong understanding of how these technologies are applied in cancer research, liquid biopsy, drug discovery and precision medicine. He has led and supported cross-functional initiatives spanning product development, market strategy, and scientific communication, with a focus on connecting life science research and biopharma segment needs to clear value propositions.
Throughout his career, Deepak Tripathi has collaborated closely with academic investigators and biopharma teams on challenges such as assay selection, analytical validation, and translational study design. This experience now informs a marketing perspective rooted in scientific rigor ensuring that messaging, education, and content reflect the realities of cancer research rather than buzzwords.
